These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 18998472)

  • 21. Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
    Clementi M; Sánchez C; Benitez DA; Contreras HR; Huidobro C; Cabezas J; Acevedo C; Castellón EA
    Prostate; 2009 Jul; 69(10):1025-33. PubMed ID: 19301301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
    Zolochevska O; Figueiredo ML
    Prostate; 2009 Oct; 69(14):1586-97. PubMed ID: 19585490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin receptors in hormone-independent prostate cancer cell line DU145: presence of two variants of angiotensin type 1 receptor.
    Sidorkiewicz M; Rebas E; Szymajda M; Ławnicka H; Pawlikowski M; Lachowicz A
    Med Sci Monit; 2009 Apr; 15(4):BR106-10. PubMed ID: 19333191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
    Nicotera TM; Schuster DP; Bourhim M; Chadha K; Klaich G; Corral DA
    Prostate; 2009 Sep; 69(12):1270-80. PubMed ID: 19475654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
    Joo SS; Yoo YM
    J Pineal Res; 2009 Aug; 47(1):8-14. PubMed ID: 19522739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipido-sterolic extract of Serenoa repens (LSESr, Permixon) treatment affects human prostate cancer cell membrane organization.
    Petrangeli E; Lenti L; Buchetti B; Chinzari P; Sale P; Salvatori L; Ravenna L; Lococo E; Morgante E; Russo A; Frati L; Di Silverio F; Russo MA
    J Cell Physiol; 2009 Apr; 219(1):69-76. PubMed ID: 19067321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. E2F1 Induces tumor cell survival via nuclear factor-kappaB-dependent induction of EGR1 transcription in prostate cancer cells.
    Zheng C; Ren Z; Wang H; Zhang W; Kalvakolanu DV; Tian Z; Xiao W
    Cancer Res; 2009 Mar; 69(6):2324-31. PubMed ID: 19276347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: inhibition of proliferation, adhesion, and motility.
    Massoner P; Colleselli D; Matscheski A; Pircher H; Geley S; Jansen Dürr P; Klocker H
    Endocr Relat Cancer; 2009 Sep; 16(3):795-808. PubMed ID: 19509068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic and antiprotozoal activity of flavonoids from Lonchocarpus spp.
    Borges-Argáez R; Balnbury L; Flowers A; Giménez-Turba A; Ruiz G; Waterman PG; Peña-Rodríguez LM
    Phytomedicine; 2007 Aug; 14(7-8):530-3. PubMed ID: 17291734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, oxidant properties, and antitumoral effects of a heteroleptic palladium(II) complex of curcumin on human prostate cancer cells.
    Valentini A; Conforti F; Crispini A; De Martino A; Condello R; Stellitano C; Rotilio G; Ghedini M; Federici G; Bernardini S; Pucci D
    J Med Chem; 2009 Jan; 52(2):484-91. PubMed ID: 19113979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
    Bose SK; Gibson W; Giri S; Nath N; Donald CD
    Prostate; 2009 Sep; 69(12):1334-42. PubMed ID: 19517575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.
    Noonan EJ; Place RF; Pookot D; Basak S; Whitson JM; Hirata H; Giardina C; Dahiya R
    Oncogene; 2009 Apr; 28(14):1714-24. PubMed ID: 19252524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
    Tezval H; Jurk S; Atschekzei F; Serth J; Kuczyk MA; Merseburger AS
    Prostate; 2009 Mar; 69(4):443-8. PubMed ID: 19058138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flavones: The Apoptosis in Prostate Cancer of Three Flavones Selected as Therapeutic Candidate Models.
    Jeong SH; Kim HH; Park MY; Bhosale PB; Abusaliya A; Won CK; Park KI; Kim E; Heo JD; Kim HW; Ahn M; Seong JK; Kim GS
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Advance of study on apoptosis inducer of several types of natural drug].
    Song Y; Zeng Y; Su L; Zhang Z
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Jun; 24(3):701-4. PubMed ID: 17713293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Apoptosis and treatment of prostate cancer: from concepts to applications, from hypothesis to reason].
    Colombel M
    Prog Urol; 2005 Dec; 15(6 Suppl 1):1225-6. PubMed ID: 16734208
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunologic functions of total flavone of Epimedium of two species in Guizhou].
    Deng W; Zheng M; Zhang J; Huang C; Zhang Y
    Zhongguo Zhong Yao Za Zhi; 2011 Feb; 36(4):511-3. PubMed ID: 21598555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anti-inflammatory activity of certain flavone derivatives].
    KROUTIL M
    Cesk Fysiol; 1960 Jul; 9():376. PubMed ID: 14412186
    [No Abstract]   [Full Text] [Related]  

  • 39. A regiodivergent synthesis of ring a C-prenylflavones.
    Minassi A; Giana A; Ech-Chahad A; Appendino G
    Org Lett; 2008 Jun; 10(11):2267-70. PubMed ID: 18454537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The coronary vasodilator activity of morpholinoethyl-3-methyl-flavone-8-carboxylate in comparison with that of other coronary vasodilators.
    SETNIKAR I; MURMANN W; RAVASI MT
    Arch Int Pharmacodyn Ther; 1961 Apr; 131():187-208. PubMed ID: 13750386
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.